An experimental treatment that uses small therapeutic agents to cross the blood-brain barrier by turning off P-glycoprotein, which prevents drugs from reaching the brain, is being seen as a possible way of treating a number of central nervous system diseases including brain cancer and neurological complications of HIV. The findings appeared online Sept. 4 in the iProceedings of the National Academy of Sciences/i, and is the result of a study from scientists ...
via Medindia Health News More READ
via Medindia Health News More READ
No comments:
Post a Comment